Stock Scorecard
Stock Summary for Elanco Animal Health Inc (ELAN) - $16.17 as of 3/28/2024 7:38:31 AM EST
Total Score
5 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ELAN
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ELAN
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ELAN
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for ELAN
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for ELAN
Financial Details for ELAN
Company Overview |
|
---|---|
Ticker | ELAN |
Company Name | Elanco Animal Health Inc |
Country | USA |
Description | Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals. The company is headquartered in Greenfield, Indiana. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/7/2024 |
Stock Price History |
|
Last Day Price | 16.17 |
Last Day Price Updated | 3/28/2024 7:38:31 AM EST |
Last Day Volume | 0 |
Average Daily Volume | 4,004,888 |
52-Week High | 16.88 |
52-Week Low | 7.88 |
Last Price to 52 Week Low | 105.20% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 100.07 |
Sector PE | 60.76 |
5-Year Average PE | 29.56 |
Free Cash Flow Ratio | 22.77 |
Industry Free Cash Flow Ratio | 12.70 |
Sector Free Cash Flow Ratio | 31.04 |
Current Ratio Most Recent Quarter | 2.75 |
Total Cash Per Share | 0.71 |
Book Value Per Share Most Recent Quarter | 12.63 |
Price to Book Ratio | 1.26 |
Industry Price to Book Ratio | 5.57 |
Sector Price to Book Ratio | 21.66 |
Price to Sales Ratio Twelve Trailing Months | 1.77 |
Industry Price to Sales Ratio Twelve Trailing Months | 13.94 |
Sector Price to Sales Ratio Twelve Trailing Months | 8.77 |
Share Statistics |
|
Total Shares Outstanding | 492,970,000 |
Market Capitalization | 7,971,324,900 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 109.70% |
Annual Earnings Growth | -1,478.21% |
Reported EPS 12 Trailing Months | -2.50 |
Reported EPS Past Year | 0.89 |
Reported EPS Prior Year | 1.11 |
Net Income Twelve Trailing Months | -1,231,000,000 |
Net Income Past Year | -1,231,000,000 |
Net Income Prior Year | -78,000,000 |
Quarterly Revenue Growth YOY | 5.10% |
5-Year Revenue Growth | -7.47% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 352,000,000 |
Total Cash Past Year | 352,000,000 |
Total Cash Prior Year | 345,000,000 |
Net Cash Position Most Recent Quarter | -5,422,000,000 |
Net Cash Position Past Year | -5,422,000,000 |
Long Term Debt Past Year | 5,774,000,000 |
Long Term Debt Prior Year | 5,836,000,000 |
Total Debt Most Recent Quarter | 5,774,000,000 |
Equity to Debt Ratio Past Year | 0.52 |
Equity to Debt Ratio Most Recent Quarter | 0.52 |
Total Stockholder Equity Past Year | 6,223,000,000 |
Total Stockholder Equity Prior Year | 7,289,000,000 |
Total Stockholder Equity Most Recent Quarter | 6,223,000,000 |
Options |
|
Put/Call Ratio | 0.04 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.06 |
MACD Signal | 0.09 |
20-Day Bollinger Lower Band | 11.91 |
20-Day Bollinger Middle Band | 14.82 |
20-Day Bollinger Upper Band | 17.73 |
Beta | 1.30 |
RSI | 51.74 |
50-Day SMA | 12.02 |
200-Day SMA | 21.66 |
System |
|
Modified | 3/27/2024 11:38:56 PM EST |